Precigen (PGEN) Current Deferred Revenue: 2012-2025
Historic Current Deferred Revenue for Precigen (PGEN) over the last 13 years, with Sep 2025 value amounting to $575,000.
- Precigen's Current Deferred Revenue fell 76.42% to $575,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $575,000, marking a year-over-year decrease of 76.42%. This contributed to the annual value of $2.5 million for FY2024, which is 8.42% up from last year.
- Per Precigen's latest filing, its Current Deferred Revenue stood at $575,000 for Q3 2025, which was down 74.23% from $2.2 million recorded in Q2 2025.
- Over the past 5 years, Precigen's Current Deferred Revenue peaked at $26.9 million during Q1 2021, and registered a low of $15,000 during Q2 2023.
- Moreover, its 3-year median value for Current Deferred Revenue was $2.2 million (2025), whereas its average is $1.8 million.
- Its Current Deferred Revenue has fluctuated over the past 5 years, first crashed by 99.94% in 2023, then soared by 14,540.00% in 2024.
- Quarterly analysis of 5 years shows Precigen's Current Deferred Revenue stood at $24.5 million in 2021, then plummeted by 92.48% to $1.8 million in 2022, then increased by 26.26% to $2.3 million in 2023, then increased by 8.42% to $2.5 million in 2024, then plummeted by 76.42% to $575,000 in 2025.
- Its Current Deferred Revenue was $575,000 in Q3 2025, compared to $2.2 million in Q2 2025 and $2.4 million in Q1 2025.